CartiHeal Performs First Agili-C(TM) Cartilage Repair Implantation Procedures at Hospital for Special Surgery (HSS), New York, NY
Kfar Saba, Israel (ots/PRNewswire) - CartiHeal, developer of Agili-C(TM), a proprietary implant for the treatment of cartilage lesions in arthritic and non-arthritic joints, announced today the successful enrollment and operation of the first two patients in the Agili-C(TM) Investigational Device Exemption (IDE) pivotal study at Hospital for Special Surgery (HSS), New York, NY. The surgeries were performed by site Principal Investigator Prof. Andreas Gomoll, MD, a sports medicine orthopedic surgeon.
Two patients were!-->…